Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00288041Phase 2Completed
Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma
Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+3 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jeffrey Weber

University of Southern California

Moderately Similar
4 trials

Shared therapeutic areas:

Stage IV MelanomaCiliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension Melanoma+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Paul Chapman

Memorial Sloan Kettering Cancer Center

Related
3 trials

Shared therapeutic areas:

Recurrent MelanomaIris MelanomaStage IV Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Sapna Patel

M.D. Anderson Cancer Center

Related
2 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeIris MelanomaRecurrent Intraocular Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Wenyin Shi, MD, PhD

Thomas Jefferson University

Related
5 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma
Similarity Score10%

Takami Sato, MD

Thomas Jefferson University

Related
2 trials

Shared therapeutic areas:

Ciliary Body and Choroid Melanoma, Medium/Large SizeIris Melanoma
Similarity Score10%

Evanthia Galanis

Mayo Clinic

Related
2 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Cassian Yee

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
3 trials

Shared therapeutic areas:

Stage IV MelanomaRecurrent Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

David Solit

Memorial Sloan Kettering Cancer Center

Related
2 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Kevin Kim

M.D. Anderson Cancer Center

Related
3 trials

Shared therapeutic areas:

Stage IV MelanomaRecurrent Melanoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Robert Vonderheide, MD, DPhil

Abramson Cancer Center at Penn Medicine

Related
3 trials

Shared therapeutic areas:

Recurrent MelanomaStage IV Melanoma
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00288041Phase 2PrincipalInvestigator

Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma

Ciliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+3 more
Completed

All 1 trials loaded